Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the ‘Company’, ‘Sona’) is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro, has been invited to showcase Sona’s developing Targeted Hyperthermia Therapy (‘THT’) cancer treatment today at the Nanotechnology Characterization Laboratory (‘NCL’). Sona will be one of six commercial and…
Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (the ‘Company’) is pleased to announce the…
Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; ‘ BRW ‘ or the ‘ Company ‘) is excited to…
In the wake of Donald Trump’s victory in the 2024 US presidential election, the cryptocurrency industry now faces the…
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (‘Energy Fuels’ or the ‘Company’), an industry leader in uranium and…
Lithium Universe Limited (referred to as ‘Lithium Universe’ or the ‘Company,’ ASX: ‘LU7”) is pleased to announce that further…
Battery metal cobalt has been in focus in recent years for its role in lithium-ion batteries, bringing attention to…
Hot on the heels of Donald Trump’s victory in the US presidential election was an important meeting of the…
Kinross Gold (TSX:K,NYSE:KGC) reported its Q3 results on Tuesday (November 5), highlighting record free cashflow supported by debt reduction…